Earkart Ltd has scheduled a board meeting for March 30, 2026, to consider variation in IPO proceeds utilization and extension of time limits for fund deployment. The company notified BSE Limited on March 20, 2026, in compliance with SEBI LODR Regulation 29. The meeting agenda focuses on modifying the objects and terms of IPO proceeds utilization, representing an important corporate governance decision for the company.

Earkart Ltd Schedules Board Meeting on March 30, 2026 to Review IPO Proceeds Utilization

Earkart Ltd has announced a board meeting scheduled for March 30, 2026, to deliberate on crucial matters related to its Initial Public Offering (IPO) proceeds utilization. The company has formally notified BSE Limited about this upcoming meeting in compliance with regulatory requirements.

Board Meeting Agenda

The primary focus of the board meeting will be to consider and approve variation in the objects and terms of utilization of IPO proceeds. Additionally, the board will discuss the extension of time limit for utilization of these proceeds.

Meeting Details: Information Date: March 30, 2026 Day: Monday Primary Agenda: Variation in IPO proceeds utilization Secondary Agenda: Extension of time limit for proceeds utilization

Regulatory Compliance

The announcement was made pursuant to Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates prior intimation of board meetings to stock exchanges when specific matters are to be considered.

The formal communication was sent to the Corporate Relationship Department of BSE Limited on March 20, 2026. The company has assured that relevant information will be made available on its official website at https://www.earkart.in .

Company Information

Corporate Details: Specifications Company Name: Earkart Ltd Former Name: Earkart Private Limited BSE Scrip Code: 544549 ISIN: INE1A8F01035

The communication was signed by Preeti Srivastava, Company Secretary & Compliance Officer (Membership No: A31615), and was digitally signed on March 20, 2026, from the company's Noida office. This board meeting represents a significant corporate governance activity as the company seeks to modify its IPO proceeds utilization framework.

Earkart Limited announced that its Board of Directors has approved two major strategic acquisitions during a meeting held on 11 March 2026. The decisions mark significant expansion moves for the company as it seeks to strengthen its manufacturing capabilities and enter the pharmaceutical sector.

Board Meeting Outcomes

The board meeting, conducted under Regulations 30 and 42 of SEBI Listing Regulations, addressed critical business expansion initiatives. The session ran from 11:30 AM to 1:20 P.M., with directors deliberating on strategic acquisition opportunities.

Decision: Details Land Acquisition: For establishing manufacturing facility Business Acquisition: Pharmaceutical business segment Meeting Duration: 11:30 AM to 1:20 P.M. Regulatory Framework: SEBI Regulations 30 and 42

Strategic Acquisitions Approved

The board approved two key acquisitions that will expand Earkart Limited's operational footprint. The first involves acquiring land specifically designated for establishing a new manufacturing facility, which will enhance the company's production capabilities. The second approval covers the acquisition of a pharmaceutical business, representing the company's strategic entry into the healthcare sector.

Compliance Acknowledgment

Earkart Limited acknowledged that the board meeting was convened on shorter notice due to the urgent nature of matters requiring immediate attention. Company Secretary Preeti Srivastava clarified that the necessary intimation to BSE, as required under Regulation 29 of SEBI LODR Regulations, was not provided within the stipulated timeframe.

The company emphasized that the delay in intimation was solely due to the urgency of matters and not due to compliance oversight. Management assured stakeholders that necessary steps are being implemented to ensure such delays do not occur in future proceedings.

Corporate Governance

The company maintains its commitment to adhering to SEBI compliance requirements and has requested BSE to take the clarification on record. All meeting outcomes and related documentation will be made available on the company's website at https://earkart.com for stakeholder reference.

Company Secretary Preeti Srivastava, with membership number A31615, signed the regulatory filings digitally on 11 March 2026, ensuring proper documentation of the board decisions and compliance clarifications.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.